SCHEMBL4919565

SCHEMBL4919565

Cc1cc(=O)oc2c3c(ccc12)N(C(=O)OCC(Cl)(Cl)Cl)C(O)C3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 3/20 0.39
▸ KDM4E B2RXH2 6/20 0.38
▸ LMNA P02545 3/20 0.38
▸ HPGD P15428 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ GAA P10253 2/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HTR1A P08908 2/20 0.37
▸ HTR2A P28223 2/20 0.37
▸ MAOB P27338 3/20 0.36
▸ ERAP1 Q9NZ08 1/20 0.36
▸ MCL1 Q07820 2/20 0.36
▸ MGAM O43451 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ SI P14410 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4927779 0.72 MAOA (0.42) MAOAKDM4ELMNAHPGDHSD17B10
SCHEMBL4929921 0.65 CA12 (0.48) KDM4ELMNAHPGDHSD17B10KMT2A
SCHEMBL14088014 0.65 CA12 (0.48) KDM4ELMNAHPGDHSD17B10KMT2A
SCHEMBL4928161 0.64 MAOA (0.47) MAOAKDM4ELMNAHPGDHSD17B10
SCHEMBL14113111 0.63 MAOA (0.48) MAOAKDM4ELMNAHPGDHSD17B10
SCHEMBL8835293 0.57 KDM4E (0.71) MAOAKDM4ELMNAHPGDHSD17B10
SCHEMBL12988158 0.57 KDM4E (0.79) MAOAKDM4ELMNAHPGDHSD17B10
SCHEMBL10627951 0.56 MAOB (0.71) MAOAKDM4ELMNAHSD17B10KMT2A
SCHEMBL4931181 0.56 CYP1A2 (0.55) KDM4ELMNAHPGDHSD17B10KMT2A
SCHEMBL12987943 0.56 KDM4E (0.65) MAOAKDM4ELMNAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE 2008-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194522-A1 Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) MAOA, MAOB, COMT MAOA 1/4885KDM4E 1183/4885LMNA 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback